NO981071L - Hydrolyse-fremmende taksan-hydrofobiske derivater - Google Patents

Hydrolyse-fremmende taksan-hydrofobiske derivater

Info

Publication number: NO981071L
Authority: NO; Norway
Prior art keywords: taxane; hydrolysis; promoting; hydrocarbon; hydrophobic derivatives
Prior art date: 1995-09-12

Application number

NO981071A

Other languages

English (en)

Other versions

NO319521B1 (no

NO981071D0 (no

Inventor

Eric Mayhew

Shaukat Ali

Andrew Stuart Janoff

Original Assignee

Liposome Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-12

Filing date

1998-03-11

Publication date

1998-05-12

1998-03-11 Application filed by Liposome Co Inc filed Critical Liposome Co Inc

1998-03-11 Publication of NO981071D0 publication Critical patent/NO981071D0/no

1998-05-12 Publication of NO981071L publication Critical patent/NO981071L/no

2005-08-22 Publication of NO319521B1 publication Critical patent/NO319521B1/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Medicinal Preparation (AREA)

NO19981071A 1995-09-12 1998-03-11 Hydrolysefremmende taksan-hydrofobiske derivater, sammensetninger og anvendelse derav. NO319521B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US357595P	1995-09-12	1995-09-12
PCT/US1996/014631 WO1997010234A1 (en)	1995-09-12	1996-09-12	Hydrolysis-promoting taxane hydrophobic derivatives

Publications (3)

Publication Number	Publication Date
NO981071D0 NO981071D0 (no)	1998-03-11
NO981071L true NO981071L (no)	1998-05-12
NO319521B1 NO319521B1 (no)	2005-08-22

Family

ID=21706522

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19981071A NO319521B1 (no)	1995-09-12	1998-03-11	Hydrolysefremmende taksan-hydrofobiske derivater, sammensetninger og anvendelse derav.

Country Status (22)

Country	Link
US (1)	US5703117A (no)
EP (1)	EP0902783B1 (no)
JP (1)	JP4192208B2 (no)
KR (1)	KR100401220B1 (no)
CN (1)	CN1100770C (no)
AT (2)	ATE216377T1 (no)
CA (1)	CA2231750C (no)
CZ (1)	CZ288562B6 (no)
DE (2)	DE69620802T2 (no)
DK (2)	DK0902783T3 (no)
ES (2)	ES2179208T3 (no)
HK (1)	HK1016169A1 (no)
HU (1)	HU226325B1 (no)
IL (1)	IL123595A (no)
MX (1)	MX9801871A (no)
NO (1)	NO319521B1 (no)
NZ (1)	NZ318300A (no)
PL (1)	PL187738B1 (no)
PT (1)	PT902783E (no)
SK (1)	SK283199B6 (no)
TR (1)	TR199800443T1 (no)
WO (1)	WO1997010234A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6107332A (en) *	1995-09-12	2000-08-22	The Liposome Company, Inc.	Hydrolysis-promoting hydrophobic taxane derivatives
US6667053B1 (en) *	1996-02-16	2003-12-23	Elan Pharmaceuticals, Inc.	D and L etherlipid stereoisomers and liposomes
US5912264A (en) *	1997-03-03	1999-06-15	Bristol-Myers Squibb Company	6-halo-or nitrate-substituted paclitaxels
US8853260B2 (en)	1997-06-27	2014-10-07	Abraxis Bioscience, Llc	Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP1964557B1 (en)	1997-11-10	2013-01-02	Memorial Sloan-Kettering Cancer Center	Process for producing arsenic trioxide formulations
BR9911031A (pt) *	1998-05-20	2002-01-29	Liposome Co Inc	Novas formulações em partìculas
US7314637B1 (en)	1999-06-29	2008-01-01	Neopharm, Inc.	Method of administering liposomal encapsulated taxane
US6146659A (en) *	1998-07-01	2000-11-14	Neopharm, Inc.	Method of administering liposomal encapsulated taxane
DE60004630T2 (de) *	1999-01-12	2004-06-17	Quanam Medical Corp., Santa Clara	Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten
EP2289549A3 (en)	1999-10-01	2011-06-15	Immunogen, Inc.	Immunoconjugates for treating cancer
EP1301500B1 (en)	2000-06-22	2007-11-21	Nitromed, Inc.	Nitrosated and nitrosylated taxanes, compositions and methods of use
US6607689B1 (en) *	2000-08-29	2003-08-19	Micron Technology, Inc.	Layer thickness control for stereolithography utilizing variable liquid elevation and laser focal length
EP1304103B1 (en) *	2001-10-22	2008-12-31	Viroblock SA	New non-phospholipid lipid vesicles (npLV) and their use in cosmetic, therapeutic and prophylactic applications
CA2466851C (en) *	2001-11-26	2012-09-11	Supergen, Inc.	Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
EP1553924B1 (en) *	2002-06-26	2010-12-08	MediGene AG	Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
BRPI0407096A (pt)	2003-02-03	2006-01-24	Neopharm Inc	Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos
WO2006089207A2 (en) *	2005-02-18	2006-08-24	Abraxis Bioscience, Inc.	Drugs with improved hydrophobicity for incorporation in medical devices
US8173167B2 (en)	2005-04-12	2012-05-08	Wisconsin Alumni Research Foundation	Micelle composition of polymer and passenger drug
MX2010011165A (es) *	2008-04-10	2011-02-22	Abraxis Bioscience Llc	Composiciones de derivados de taxano hidrofobos y sus usos.
KR20150136137A (ko) *	2008-04-10	2015-12-04	아브락시스 바이오사이언스, 엘엘씨	소수성 탁산 유도체의 조성물 및 그의 용도
WO2011038278A2 (en)	2009-09-25	2011-03-31	Wisconsin Alumni Research Foundation	Micelle encapsulation of therapeutic agents
CN105503844A (zh) *	2015-12-11	2016-04-20	上海大学	C-13和c-7位结构改造的紫杉醇类化合物及其制备方法
CN111004195B (zh) *	2019-12-03	2022-01-28	沈阳药科大学	卡巴他赛弱碱性衍生物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5059699A (en) *	1990-08-28	1991-10-22	Virginia Tech Intellectual Properties, Inc.	Water soluble derivatives of taxol
US5278324A (en) *	1990-08-28	1994-01-11	Virginia Tech Intellectual Properties, Inc.	Water soluble derivatives of taxol
DK1251127T3 (da) *	1992-12-23	2006-03-06	Bristol Myers Squibb Co	Nye sidekædede-bærende taxaner og mellemprodukter deraf
IL108316A (en) *	1993-01-15	2006-10-31	Univ Florida State	History of C-10 Texan and pharmaceuticals containing them
US5580899A (en) *	1995-01-09	1996-12-03	The Liposome Company, Inc.	Hydrophobic taxane derivatives

1996
- 1996-09-12 SK SK334-98A patent/SK283199B6/sk unknown
- 1996-09-12 DK DK96930847T patent/DK0902783T3/da active
- 1996-09-12 PT PT96930847T patent/PT902783E/pt unknown
- 1996-09-12 TR TR1998/00443T patent/TR199800443T1/xx unknown
- 1996-09-12 ES ES96930847T patent/ES2179208T3/es not_active Expired - Lifetime
- 1996-09-12 CZ CZ1998711A patent/CZ288562B6/cs not_active IP Right Cessation
- 1996-09-12 DK DK02008590T patent/DK1229030T3/da active
- 1996-09-12 AT AT96930847T patent/ATE216377T1/de not_active IP Right Cessation
- 1996-09-12 US US08/712,684 patent/US5703117A/en not_active Expired - Fee Related
- 1996-09-12 HU HU9901433A patent/HU226325B1/hu unknown
- 1996-09-12 DE DE69620802T patent/DE69620802T2/de not_active Expired - Fee Related
- 1996-09-12 KR KR10-1998-0701653A patent/KR100401220B1/ko not_active IP Right Cessation
- 1996-09-12 ES ES02008590T patent/ES2252347T3/es not_active Expired - Lifetime
- 1996-09-12 CA CA002231750A patent/CA2231750C/en not_active Expired - Fee Related
- 1996-09-12 CN CN96198237A patent/CN1100770C/zh not_active Expired - Fee Related
- 1996-09-12 WO PCT/US1996/014631 patent/WO1997010234A1/en active IP Right Grant
- 1996-09-12 AT AT02008590T patent/ATE309235T1/de not_active IP Right Cessation
- 1996-09-12 MX MX9801871A patent/MX9801871A/es not_active IP Right Cessation
- 1996-09-12 IL IL12359596A patent/IL123595A/xx not_active IP Right Cessation
- 1996-09-12 PL PL96325477A patent/PL187738B1/pl not_active IP Right Cessation
- 1996-09-12 NZ NZ318300A patent/NZ318300A/xx unknown
- 1996-09-12 JP JP51210297A patent/JP4192208B2/ja not_active Expired - Fee Related
- 1996-09-12 DE DE69635428T patent/DE69635428T2/de not_active Expired - Fee Related
- 1996-09-12 EP EP96930847A patent/EP0902783B1/en not_active Expired - Lifetime
1998
- 1998-03-11 NO NO19981071A patent/NO319521B1/no unknown
1999
- 1999-03-18 HK HK99101119A patent/HK1016169A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT902783E (pt)	2002-09-30
NO319521B1 (no)	2005-08-22
CA2231750A1 (en)	1997-03-20
IL123595A0 (en)	1998-10-30
ES2179208T3 (es)	2003-01-16
DE69635428T2 (de)	2006-06-14
IL123595A (en)	2000-10-31
HUP9901433A3 (en)	2001-05-28
DE69635428D1 (de)	2005-12-15
CN1100770C (zh)	2003-02-05
EP0902783B1 (en)	2002-04-17
NO981071D0 (no)	1998-03-11
DE69620802D1 (de)	2002-05-23
CA2231750C (en)	2006-07-11
WO1997010234A1 (en)	1997-03-20
ATE309235T1 (de)	2005-11-15
PL325477A1 (en)	1998-07-20
JP4192208B2 (ja)	2008-12-10
CZ288562B6 (cs)	2001-07-11
KR100401220B1 (ko)	2004-03-20
TR199800443T1 (xx)	1998-06-22
ES2252347T3 (es)	2006-05-16
ATE216377T1 (de)	2002-05-15
AU706290B2 (en)	1999-06-10
EP0902783A1 (en)	1999-03-24
JP2001519755A (ja)	2001-10-23
NZ318300A (en)	1999-08-30
EP0902783A4 (no)	1999-03-24
KR19990044409A (ko)	1999-06-25
PL187738B1 (pl)	2004-09-30
AU6975696A (en)	1997-04-01
DK1229030T3 (da)	2006-02-13
CN1202166A (zh)	1998-12-16
DK0902783T3 (da)	2002-07-22
SK33498A3 (en)	1998-08-05
HK1016169A1 (en)	1999-10-29
CZ71198A3 (cs)	1998-07-15
SK283199B6 (sk)	2003-03-04
US5703117A (en)	1997-12-30
HUP9901433A2 (hu)	2001-04-28
DE69620802T2 (de)	2002-10-10
MX9801871A (es)	1998-05-31
HU226325B1 (en)	2008-08-28

Publication	Publication Date	Title
DK0902783T3 (da)	2002-07-22	Hydrolysefremmende, hydrofobe taxanderivater
ATE219363T1 (de)	2002-07-15	Lösliche prodrugs von paclitaxel
PT802911E (pt)	2002-05-31	Derivados de taxano hidrofobos
CA2301057A1 (en)	2000-01-13	A method of administering liposomal encapsulated taxane
DE69226197D1 (de)	1998-08-13	Hämoglobine als arzneimittelabgabesystem
TR200102603T2 (tr)	2002-01-21	Antitümör aktiviteye sahip olan kamptotesin türevleri
PT977564E (pt)	2005-08-31	Forscolina para promocao da massa corporal magra
DE59611341D1 (de)	2006-06-01	Verwendung von saccharid-konjugaten
ES2052717T3 (es)	1994-07-16	Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
PT745075E (pt)	2002-05-31	Derivados substituidos em 6 do acido micofenolico com actividade imunossupressora
CY1109695T1 (el)	2014-08-13	Μικροοργανισμοι αποδομησης οξαλικου ή ενζυμα αποδομησης οξαλικου για την προληψη παθησης σχετιζομενης με οξαλικο
ATE262515T1 (de)	2004-04-15	Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
SE8404283L (sv)	1986-03-01	Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
ES2038642T3 (es)	1993-08-01	Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
ATE141796T1 (de)	1996-09-15	2',5'-oligoadenylat-derivate zur verwendung als heilmittel
EP1229030A3 (en)	2002-09-25	Hydrolysis-promoting taxane hydrophobic derivates
TR199901395T2 (xx)	1999-11-22	Yeni karboksi ikameli siklik karboksamid t�revleri.
ES8605989A1 (es)	1986-04-01	Un metodo de preparar un complejo de fibronectina, dextrano y farmaco
RU94018405A (ru)	1996-04-27	Устройство для воздействия магнитным полем
IT8620514V0 (it)	1986-01-17	Struttura di cannula vaginale monouso, per l'applicazione di pomate, medicamenti semidensi e simili.
MX9709683A (es)	1998-06-28	Uso de derivados de vitamina d4 para tratamiento contra el cancer.